Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06888479
PHASE3

Optimal Timing of Hepatitis B Vaccination After Transplants

Sponsor: Institute of Hematology & Blood Diseases Hospital, China

View on ClinicalTrials.gov

Summary

The investigators aim to perform a randomized clinical trial to determine the optimal timing of hepatitis B vaccination after hematopoietic cell transplantation (HCT) through evaluating the immunity effect of two different vaccination schedules (initiated at 3 or 6 months after transplantation) in patients with different immune reconstitution status.

Official title: Optimal Timing of Hepatitis B Vaccination After Transplants: a Randomized Clinical Study

Key Details

Gender

All

Age Range

16 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1500

Start Date

2025-06-01

Completion Date

2029-03-01

Last Updated

2025-03-21

Healthy Volunteers

No

Interventions

BIOLOGICAL

hepatitis B vaccine

Three doses of hepatitis B vaccine

Locations (1)

Institute of Hematology & Blood Diseases Hospital

Tianjin, Tianjin Municipality, China